More articles from Pharmacology and Therapeutics

Open Access
Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy
Gemma V. Brierley, Hannah Webber, Eerika Rasijeff, Sarah Grocott, Kenneth Siddle, Robert K. Semple

Diabetes Nov 2020, 69 (11) 2481-2489; DOI: 10.2337/db20-0345
Open Access
Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
Matthew J. Singleton, Elsayed Z. Soliman, Alain G. Bertoni, S. Patrick Whalen, Prashant D. Bhave, Joseph Yeboah

Diabetes Oct 2020, 69 (10) 2186-2193; DOI: 10.2337/db20-0401
You have access
A Small Molecule, UAB126, Reverses Diet-Induced Obesity and its Associated Metabolic Disorders
Guang Ren, Teayoun Kim, Hae-Suk Kim, Martin E. Young, Donald D. Muccio, Venkatram R. Atigadda, Samuel I. Blum, Hubert M. Tse, Kirk M. Habegger, Sushant Bhatnagar, Tatjana Coric, Mary-Ann Bjornsti, Anath Shalev, Stuart J. Frank, Jeong-a Kim

Diabetes Sep 2020, 69 (9) 2003-2016; DOI: 10.2337/db19-1001
Open Access
GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
Alexander S. Christensen, Sofie Hædersdal, Heidi Storgaard, Kathrine Rose, Nina L. Hansen, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll

Diabetes Sep 2020, 69 (9) 1989-2002; DOI: 10.2337/db20-0074
You have access
Connecting Rodent and Human Pharmacokinetic Models for the Design and Translation of Glucose-Responsive Insulin
Jing Fan Yang, Xun Gong, Naveed A. Bakh, Kelley Carr, Nelson F.B. Phillips, Faramarz Ismail-Beigi, Michael A. Weiss, Michael S. Strano

Diabetes Aug 2020, 69 (8) 1815-1826; DOI: 10.2337/db19-0879
Open Access
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
Jay M. Sosenko, Jay S. Skyler, Kevan C. Herold, Desmond A. Schatz, Michael J. Haller, Alberto Pugliese, Mario Cleves, Susan Geyer, Lisa E. Rafkin, Della Matheson, Jerry P. Palmer

Diabetes Aug 2020, 69 (8) 1827-1832; DOI: 10.2337/db20-0166
You have access
Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice
Xiaodong Sun, Fang Han, Qingguo Lu, Xuan Li, Di Ren, Jingwen Zhang, Ying Han, Yang K. Xiang, Ji Li

Diabetes Jun 2020, 69 (6) 1292-1305; DOI: 10.2337/db19-0991
You have access
A Phenotypic Screen Identifies Calcium Overload as a Key Mechanism of β-Cell Glucolipotoxicity
Jennifer Vogel, Jianning Yin, Liansheng Su, Sharon X. Wang, Richard Zessis, Sena Fowler, Chun-Hao Chiu, Aaron C. Wilson, Amy Chen, Frederic Zecri, Gordon Turner, Thomas M. Smith, Brian DeChristopher, Heming Xing, Deborah M. Rothman, Xinming Cai, Alina Berdichevsky

Diabetes May 2020, 69 (5) 1032-1041; DOI: 10.2337/db19-0813
You have access
Effects of Vitamin D Receptor Knockout and Vitamin D Deficiency on Corneal Epithelial Wound Healing and Nerve Density in Diabetic Mice
Xiaowen Lu, Sarah Vick, Zhong Chen, Jie Chen, Mitchell A. Watsky

Diabetes May 2020, 69 (5) 1042-1051; DOI: 10.2337/db19-1051
Open Access
MG53 Does Not Manifest the Development of Diabetes in db/db Mice
Qiang Wang, Zehua Bian, Qiwei Jiang, Xiaoliang Wang, Xinyu Zhou, Ki Ho Park, Willa Hsueh, Bryan A. Whitson, Erin Haggard, Haichang Li, Ken Chen, Chuanxi Cai, Tao Tan, Hua Zhu, Jianjie Ma

Diabetes May 2020, 69 (5) 1052-1064; DOI: 10.2337/db19-0807

Main menu

User menu

Search

More articles from Pharmacology and Therapeutics

Pages

Navigate

More Information

Other ADA Resources